Doctor profile · Federal record
Dr. MARY GRACE GOROSPE, PA-C
Physician Assistant · ROSEVILLE, CA
- NPI 1477828150
- Accepts Medicare
- MIPS 90.0 / 100 · 2023
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5 MEDICAL PLAZA DR STE 190
ROSEVILLE, CA 956612867
(916) 786-7498
fax (916) 786-2715 - Mailing address
-
1300 ETHAN WAY STE 600
SACRAMENTO, CA 958252296
Credentials & registration
- NPI registered
- March 2012 — 14 yrs on file
- Profile last updated
- July 9, 2021
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- California #52728
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477828150. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
564
Distinct HCPCS
8
Medicare allowed
$50,579
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 266 | 175 | $81 | |
99308 |
Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | 80 | 17 | $65 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 66 | 65 | $113 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 48 | 43 | $114 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 39 | 33 | $69 | |
99495 |
Transitional care management services for problem of at least moderate complexity | 35 | 30 | $183 | |
99309 |
Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 17 | 14 | $94 | |
94618 |
Test for exercise-induced lung stress | 13 | 13 | $30 |
In context: peer comparison
Among 19 peers in this city , average services per provider: 146. This provider delivers 3.9× the peer median.Open Payments
Industry payments received
All-time total
$3,316
Transactions
163
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $614.10 | |
| GlaxoSmithKline, LLC. | 22 | $379.71 | |
| United Therapeutics Corporation | 20 | $356.41 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $284.42 | |
| ViiV Healthcare Company | 14 | $224.15 | |
| Regeneron Healthcare Solutions, Inc. | 9 | $194.21 | |
| Amgen Inc. | 11 | $192.88 | |
| Astellas Pharma US Inc | 3 | $154.02 | |
| Merck Sharp & Dohme LLC | 8 | $153.32 | |
| ABBVIE INC. | 9 | $145.44 | |
| Insmed, Inc. | 5 | $113.57 | |
| Baxter Healthcare | 5 | $94.46 | |
| Electromed, Inc. | 13 | $65.49 | |
| La Jolla Pharmaceutical Company | 3 | $61.52 | |
| Pulmonx Corporation | 2 | $48.68 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
962
Patients
300
Total drug cost
$386,681
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 129 | 54 | $5,160 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 124 | 28 | $107,088 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 106 | 24 | $65,023 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 81 | 24 | $69,869 |
| Prednisone | Generic | 74 | 38 | $349 |
| Montelukast Sodium | Generic | 64 | 14 | $1,748 |
| Azelastine Hcl | Generic | 55 | 18 | $2,030 |
| Azithromycin | Generic | 54 | 37 | $945 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 54 | 18 | $3,798 |
| Stiolto Respimat (Tiotropium Br/Olodaterol Hcl) | Brand | 49 | 17 | $37,198 |